Dr. Brutlag's primary interest is to understand the flow of information from the genome to the phenotype of an organism.

Dr. Brunet's laboratory's overarching goal is to understand the genetic mechanisms of aging and longevity.

Dr. Brown's laboratory investigates the gene expression scripts of the yeast and human genomes - their organization, physiological logic and the molecular mechanisms that control them.

Dr. Brown and his research group focus on chemical and microbiological interactions at environmental interfaces, which are defined as interfaces between solids and aqueous solutions, solids and gases, aqueous solutions and gases, solids and microbial organisms (including microbial biofilms), and solids and natural organic matter.

Dr. James Brooks's group's interest is in developing diagnostic and prognostic markers for urological diseases. Their work spans discovery, measurement methodologies, and clinical validation of candidate biomarkers. They have primarily used genomic and proteomic approaches for biomarker discovery. While their primary focus has been in prostate cancer, we have also worked in kidney cancer and other malignancies.

Dr. Bronte-Stewart's laboratory research focus is human motor control and brain pathophysiology in movement disorders.

Dr. Boyd's laboratory's goal is to understand the lymphocyte genotype-phenotype relationships in healthy human immunity and in immunological diseases.

Dr. Brongersma's current research is directed towards the development and physical analysis of nanostructured materials that find application in nanoscale electronic and photonic devices.

Dr. Zarins is the Walter Clifford Chidester and Elsa Rooney Chidester Professor of Vascular Surgery, Emeritus.

Dr. Shortliffe's laboratory group studies the interaction between urinary tract pressures and renal tubular and glomerular changes have not been well outlined.